BTMD logo

biote Corp. (BTMD)

Profile

Full Name

biote Corp.

Ticker

NASDAQ: BTMD

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Care Facilities

Country

United States

IPO

April 28, 2021

Indexes

Not included

Website

https://www.biote.com

Employees

217

Key Details

Price

$2.55(-0.78%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$197.19M(6.38% YoY)

Annual EPS

$0.09(-28.60% YoY)

PE Ratio

3.21

Next earnings date

Mar 11, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.55
    BTMD price is $2.55

    30-Day Relative Volume

    1.05
    BTMD 30-day relative volume is 1.05

    Price Performance

    Price Most Recent Change

    -0.78%
    BTMD price was down -0.78% on Dec 5, 2025

    Price YTD Change

    -58.74%
    BTMD price is down -58.74% since January 1st

    Price 1-Year Change

    -60.28%
    BTMD price is down -60.28% year-on-year

    Price 3-Year Change

    -39.86%
    BTMD price is down -39.86% over the past 3 years

    Price Range

    Price All-Time High

    $10.53
    BTMD price is currently -75.77% below its historical high of $10.53

    Price 3-Year Low

    $2.31
    BTMD price is currently +10.15% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $78.24M
    BTMD market cap is $78.24 million

    Market Cap 3-Year Change

    +98.99%
    BTMD market cap is up +98.99% over the past 3 years

    Market Cap All-Time High

    $319.44M
    BTMD market cap is currently -75.51% below its historical high of $319.44 million

    Market Cap Sector Percentile

    37.95%
    BTMD market cap is higher than 37.95% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -1.39%
    BTMD shares outstanding is down -1.39% year-on-year

    Shares Outstanding 3-Year Change

    +230.87%
    BTMD shares outstanding is up +230.87% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.22
    BTMD beta is 1.22

    200-day SMA

    $3.48
    BTMD price is currently -26.64% below its 200-day simple moving average

    50-day SMA

    $2.76
    BTMD price is currently -7.72% below its 50-day simple moving average

    14-Day RSI

    45.23
    BTMD 14-day relative strength index is 45.23

    Volume

    1.05
    BTMD 30-day relative volume is 1.05

    ATR

    $0.15
    BTMD average true range is $0.15

    10-day Historical Volatility

    67.29%
    BTMD 10-day historical volatility is 67.29%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $197.19M
    BTMD annual revenue is $197.19 million

    Revenue Analysts Estimate

    $191.65M
    BTMD annual revenue is currently +2.89% higher than the consensus analysts' forecast

    Revenue 1-Year Change

    +6.38%
    BTMD annual revenue is up +6.38% year-on-year

    Revenue Sector Percentile

    73.81%
    BTMD annual revenue is higher than 73.81% of companies in Healthcare sector

    EPS

    EPS

    $0.09
    BTMD annual earnings per share is $0.09

    EPS Analysts Estimate

    $0.68
    BTMD annual earnings per share is currently -86.46% lower than the consensus analysts' forecast

    EPS 1-Year Change

    -28.6%
    BTMD annual earnings per share is down -28.6% year-on-year

    EPS Sector Percentile

    82.86%
    BTMD annual earnings per share is higher than 82.86% of companies in Healthcare sector

    Profit

    Gross Profit

    $139.06M
    BTMD annual gross profit is $139.06 million

    Gross Margin

    70.52%
    BTMD annual gross profit margin is 70.52%

    Operating Profit

    $31.61M
    BTMD annual operating income is $31.61 million

    Operating Margin

    16.03%
    BTMD annual operating profit margin is 16.03%

    Net Income

    $46.00K
    BTMD annual net profit is $46.00 thousand

    Net Margin

    1.60%
    BTMD annual net profit margin is 1.60%

    Expenses

    Total Expenses

    $165.58M
    BTMD annual total expenses is $165.58 million

    Operating Expenses

    $107.45M
    BTMD annual total operating expenses is $107.45 million

    Cost Of Goods Sold

    $58.13M
    BTMD annual cost of goods sold is $58.13 million

    Selling, General & Administrative Expenses

    $107.45M
    BTMD annual SG&A is $107.45 million

    Depreciation & Amortization

    $3.57M
    BTMD annual D&A is $3.57 million

    Interest Expense

    $11.00M
    BTMD annual interest expense is $11.00 million

    Income Tax

    $970.00K
    BTMD annual income tax is $970.00 thousand

    EBIT & EBITDA

    EBIT

    $12.02M
    BTMD annual earnings before interest & taxes is $12.02 million

    EBITDA

    $15.59M
    BTMD annual EBITDA is $15.59 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $122.37M
    BTMD annual total assets is $122.37 million

    Non Current Assets

    $54.24M
    BTMD annual long term assets is $54.24 million

    Current Assets

    $68.13M
    BTMD annual total current assets is $68.13 million

    Cash and Cash Equivalents

    $39.34M
    BTMD annual cash & cash equivalents is $39.34 million

    Accounts Receivable

    $7.63M
    BTMD annual accounts receivable is $7.63 million

    Inventory

    $17.65M
    BTMD annual inventory is $17.65 million

    Liabilities

    Total Liabilities

    $224.57M
    BTMD annual total liabilities is $224.57 million

    Long Term Liabilities

    $173.06M
    BTMD annual total long term liabilities is $173.06 million

    Current Liabilities

    $51.51M
    BTMD annual current liabilities is $51.51 million

    Accounts Payable

    $5.81M
    BTMD annual accounts payable is $5.81 million

    Debt

    Total Debt

    $179.74M
    BTMD annual total debt is $179.74 million

    Total Debt 1-Year Change

    +56.47%
    BTMD annual total debt is up +56.47% year-on-year

    Long Term Debt

    $148.39M
    BTMD annual long term debt is $148.39 million

    Short Term Debt

    $31.35M
    BTMD annual short term debt is $31.35 million

    Equity & Capital

    Shareholders Equity

    -$105.93M
    BTMD annual stockholders equity is -$105.93 million

    Book Value

    -$105.93M
    BTMD annual book value is -$105.93 million

    Retained Earnings

    -$100.30M
    BTMD annual retained earnings is -$100.30 million

    Working Capital

    $16.61M
    BTMD annual working capital is $16.61 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    $45.24M
    BTMD annual cash from operations is $45.24 million

    Cash From Operations 1-Year Change

    +68.3%
    BTMD annual cash from operations is up +68.3% year-on-year

    Cash From Investing

    -$18.80M
    BTMD annual cash from investing is -$18.80 million

    Cash From Investing 1-Year Change

    -592.89%
    BTMD annual cash from investing is down -592.89% year-on-year

    Cash From Financing

    -$76.08M
    BTMD annual cash from financing is -$76.08 million

    Cash From Financing 1-Year Change

    -429.09%
    BTMD annual cash from financing is down -429.09% year-on-year

    CAPEX

    CAPEX

    $6.96M
    BTMD annual capital expenditures is $6.96 million

    CAPEX 1-Year Change

    +156.4%
    BTMD annual capital expenditures is up +156.4% year-on-year

    Free Cash Flow

    Free Cash Flow

    $38.29M
    BTMD annual free cash flow is $38.29 million

    Free Cash Flow 1-Year Change

    +58.41%
    BTMD annual free cash flow is up +58.41% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    70.52%
    BTMD annual gross profit margin is 70.52%

    Operating Margin

    16.03%
    BTMD annual operating profit margin is 16.03%

    Net Margin

    1.60%
    BTMD annual net profit margin is 1.60%

    ROA & ROE

    ROA

    0.03%
    BTMD annual return on assets is 0.03%

    ROE

    -0.04%
    BTMD annual return on equity is -0.04%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    3.21
    BTMD price to earnings ratio is 3.21

    PE Ratio Sector Percentile

    4.33%
    BTMD price to earnings ratio is higher than 4.33% of companies in Healthcare sector

    PB Ratio

    PB Ratio

    -1.08
    BTMD price to book ratio is -1.08

    PB Ratio Sector Percentile

    10%
    BTMD price to book ratio is higher than 10% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    0.40
    BTMD price to sales ratio is 0.40

    PS Ratio Sector Percentile

    11.73%
    BTMD price to sales ratio is higher than 11.73% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $197.06M
    BTMD enterprise value is $197.06 million

    Enterprise Value Sector Percentile

    52.35%
    BTMD enterprise value is higher than 52.35% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    4.40
    BTMD EV/EBITDA is 4.40

    EV/EBITDA Sector Percentile

    74.57%
    BTMD EV/EBITDA is higher than 74.57% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    1.32
    BTMD annual current ratio is 1.32

    Quick Ratio

    0.98
    BTMD annual quick ratio is 0.98

    Leverage

    Debt To Equity

    -1.70
    BTMD annual debt to equity ratio is -1.70

    Interest Coverage Ratio

    1.09
    BTMD annual interest coverage ratio is 1.09

    Risk & Stability

    F-Score

    8
    BTMD piotroski f-score is 8

    Altman Z-Score

    1.16
    BTMD altman z-score is 1.16

    Analyst ratings

    Recent major analysts updates

    Aug 7, 25 B. Riley Securities
    Neutral
    Mar 13, 25 Craig-Hallum
    Buy
    Dec 16, 24 Craig-Hallum
    Buy
    Mar 13, 24 Roth MKM
    Buy
    Feb 20, 24 B. Riley Securities
    Buy
    Feb 1, 24 Jefferies
    Buy
    Jan 18, 24 Truist Securities
    Buy
    Jan 18, 24 Roth MKM
    Buy
    Aug 15, 23 TD Cowen
    Outperform
    Aug 14, 23 Roth MKM
    Buy

    Institutional Ownership

    Screeners with BTMD included

    US stocks
    High Piotroski score stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for biote Corp.?
    • Does biote Corp. pay dividends?
    • What sector is biote Corp. in?
    • What industry is biote Corp. in?
    • What country is biote Corp. based in?
    • When did biote Corp. go public?
    • Is biote Corp. in the S&P 500?
    • Is biote Corp. in the NASDAQ 100?
    • Is biote Corp. in the Dow Jones?
    • When was biote Corp.'s last earnings report?
    • When does biote Corp. report earnings?

    What is the ticker symbol for biote Corp.?

    The ticker symbol for biote Corp. is NASDAQ:BTMD

    Does biote Corp. pay dividends?

    No, biote Corp. does not pay dividends

    What sector is biote Corp. in?

    biote Corp. is in the Healthcare sector

    What industry is biote Corp. in?

    biote Corp. is in the Medical Care Facilities industry

    What country is biote Corp. based in?

    biote Corp. is headquartered in United States

    When did biote Corp. go public?

    biote Corp.'s initial public offering (IPO) was on April 28, 2021

    Is biote Corp. in the S&P 500?

    No, biote Corp. is not included in the S&P 500 index

    Is biote Corp. in the NASDAQ 100?

    No, biote Corp. is not included in the NASDAQ 100 index

    Is biote Corp. in the Dow Jones?

    No, biote Corp. is not included in the Dow Jones index

    When was biote Corp.'s last earnings report?

    biote Corp.'s most recent earnings report was on November 5, 2025

    When does biote Corp. report earnings?

    The next expected earnings date for biote Corp. is March 11, 2026
    On this page